ACS applied materials & interfaces

Lipid Nanoparticles with Ionizable Sterols for Local mRNA Vaccine Delivery That Boosts Immune Cell Responses

Updated

Abstract

ISL-3C-LNPs demonstrated high mRNA encapsulation and delivery efficiency.

  • Traditional lipid nanoparticles face challenges in liver-targeted transfection and cellular immune response activation.
  • CS22021-based ISL-3C-LNPs enable localized mRNA delivery at the injection site after intramuscular administration.
  • These LNPs may offer a better safety profile due to their localized delivery.
  • The CS22021-based formulation efficiently delivers a varicella-zoster virus mRNA vaccine, producing strong immune responses.
  • A significantly higher CD8T cell response is associated with the CS22021-based ISL-3C-LNP compared to conventional LNP formulations.

Simplified

Full Text

Full text is available at the source.

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free